A detailed history of Susquehanna International Group, LLP transactions in United Therapeutics Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 19,436 shares of UTHR stock, worth $7.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,436
Previous 16,408 18.45%
Holding current value
$7.06 Million
Previous $5.23 Million 33.26%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$311.04 - $363.55 $941,829 - $1.1 Million
3,028 Added 18.45%
19,436 $6.96 Million
Q2 2024

Aug 15, 2024

SELL
$228.26 - $319.04 $4.17 Million - $5.83 Million
-18,273 Reduced 52.69%
16,408 $5.23 Million
Q1 2024

May 07, 2024

BUY
$210.76 - $249.51 $2.79 Million - $3.3 Million
13,242 Added 61.77%
34,681 $7.97 Million
Q4 2023

Feb 14, 2024

SELL
$214.88 - $256.94 $9.05 Million - $10.8 Million
-42,100 Reduced 66.26%
21,439 $4.71 Million
Q3 2023

Nov 14, 2023

BUY
$211.82 - $248.24 $1.2 Million - $1.41 Million
5,686 Added 9.83%
63,539 $14.4 Million
Q2 2023

Aug 11, 2023

SELL
$205.19 - $232.99 $6.1 Million - $6.93 Million
-29,731 Reduced 33.95%
57,853 $12.8 Million
Q1 2023

May 16, 2023

BUY
$212.99 - $276.17 $13.1 Million - $17 Million
61,403 Added 234.53%
87,584 $19.6 Million
Q4 2022

Feb 14, 2023

SELL
$205.95 - $280.43 $1.53 Million - $2.08 Million
-7,417 Reduced 22.08%
26,181 $7.28 Million
Q3 2022

Nov 14, 2022

BUY
$203.3 - $244.17 $6.48 Million - $7.79 Million
31,889 Added 1865.94%
33,598 $7.04 Million
Q2 2022

Aug 15, 2022

SELL
$174.81 - $241.14 $1.05 Million - $1.45 Million
-6,006 Reduced 77.85%
1,709 $403,000
Q1 2022

May 16, 2022

SELL
$166.16 - $213.96 $427,529 - $550,519
-2,573 Reduced 25.01%
7,715 $1.38 Million
Q4 2021

Feb 14, 2022

SELL
$184.32 - $216.08 $7.18 Million - $8.42 Million
-38,963 Reduced 79.11%
10,288 $2.22 Million
Q3 2021

Nov 15, 2021

BUY
$179.86 - $214.88 $7.63 Million - $9.11 Million
42,419 Added 620.89%
49,251 $9.09 Million
Q2 2021

Aug 11, 2021

SELL
$170.47 - $211.93 $4.59 Million - $5.71 Million
-26,952 Reduced 79.78%
6,832 $1.23 Million
Q1 2021

May 17, 2021

BUY
$153.94 - $174.85 $1.37 Million - $1.55 Million
8,875 Added 35.63%
33,784 $5.65 Million
Q4 2020

Feb 16, 2021

BUY
$101.87 - $151.79 $1.63 Million - $2.43 Million
15,992 Added 179.34%
24,909 $3.78 Million
Q3 2020

Nov 16, 2020

BUY
$99.9 - $121.13 $205,494 - $249,164
2,057 Added 29.99%
8,917 $901,000
Q2 2020

Aug 14, 2020

SELL
$92.74 - $125.82 $751,935 - $1.02 Million
-8,108 Reduced 54.17%
6,860 $830,000
Q1 2020

May 15, 2020

SELL
$79.39 - $115.35 $812,477 - $1.18 Million
-10,234 Reduced 40.61%
14,968 $1.42 Million
Q4 2019

Feb 14, 2020

SELL
$78.31 - $95.34 $3.33 Million - $4.05 Million
-42,516 Reduced 62.78%
25,202 $2.22 Million
Q3 2019

Nov 14, 2019

BUY
$74.85 - $85.99 $1.49 Million - $1.71 Million
19,931 Added 41.71%
67,718 $5.4 Million
Q2 2019

Aug 16, 2019

SELL
$76.06 - $120.81 $1.82 Million - $2.89 Million
-23,952 Reduced 33.39%
47,787 $3.73 Million
Q4 2017

Feb 14, 2018

BUY
$118.58 - $151.28 $8.51 Million - $10.9 Million
71,739
71,739 $10.6 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.